FDA reclassifies NRx Pharmaceuticals ketamine application amendment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. META
2. NVDA
3. SPY
4. USO
5. GS
6. PSKY
7. VRTX
8. LGND
9. ONON
10. DCOY

Go back to FDA reclassifies NRx Pharmaceuticals ketamine application amendment
(NASDAQ: NRXP) Delayed: 3.23 -0.06 (1.82%)
Previous Close $3.29    52 Week High $ 
Open $3.30    52 Week Low $ 
Day High $3.31    P/E N/A 
Day Low $3.21    EPS $ 
Volume 242,332